There is no reliable side-effect list
KPV’s effects in people have not been established through human treatment studies in the review checked September 28, 2026.
The lack of a reported problem is not evidence that KPV is safe.
If someone says KPV is safe, ask for studies or patient records showing what happened to people who received it.
Basic testing is missing too
In its review checked September 28, 2026, FDA found no animal studies assessing KPV’s short-term or repeated-use toxicity—its potential to cause harm.
It also found no studies of damage to genes—the instructions inside cells—or effects on having children or on a baby’s growth before birth. Studies of cancer risk were missing too.
Those are gaps in knowledge, rather than measured rates of harm.
Possible harms have not been measured in people
FDA’s review checked September 28, 2026 raises concerns that KPV could trigger the body’s defence system or that KPV molecules could stick together in clumps.
A reaction by the body’s defence system is called an immune response. The review found no studies or patient records measuring such a reaction to KPV in people. It cannot tell us what symptoms that reaction would cause or how often it might happen.
The review also found too little information from people to rule out the risk of KPV forming clumps.
A discussion of care needs to make room for what is missing, as well as what is hoped for.